Study of ziconotide pain treatment in routine care
Treatments studied
Part of Pain clinical trials.
This study follows adults with severe, long-lasting pain that has not responded to other treatments, to see how the pain medicine ziconotide works in everyday clinical practice. You may be considered if you’re being evaluated for an implanted pain-delivery system that gives ziconotide into the spinal fluid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have severe chronic pain that has not improved with other treatments
- Be a candidate for an implanted system that delivers pain medicine into the spinal fluid (intrathecal therapy)
- Be planned to receive ziconotide as part of that spinal-fluid pain treatment
- Understand the study and agree to join
- Do not have medical reasons you cannot safely take ziconotide
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a medicine called ziconotide, given through a pump in your spine (intrathecal delivery) to treat chronic pain that is not from cancer. It aims to learn how safe and effective this treatment is in real-world patients.
This trial tests a spinal pump delivering ziconotide to treat nerve pain caused by chemotherapy. It may help patients who have tried other pain medicines but still have significant pain.
This trial tests a medicine called CNTX-3001, given as a spinal injection, for people with long-term, severe low back pain that hasn't improved with other treatments.
This study tests a new medication (ITX24-01) given as injections during a procedure called radiofrequency ablation, which uses heat to treat chronic neck or lower back pain from the small joints along the spine. The medication may help reduce pain and improve your ability to function.
This early-phase study tests a targeted injection (based on resiniferatoxin) to reduce severe pain caused by cancer in the bones. You must first respond to a local anesthetic “test injection,” because that response helps confirm the pain pathway the study targets.
This study tests new treatments for chronic pain that lasts at least 3 months. Participants must stop their regular pain medicines and use only a rescue painkiller if needed. The goal is to find better ways to manage long-term pain.
Hear when a new Refractory Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.